• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ZLD 4.11% 70.0¢

ZELIRA THERAPEUTICS LIMITED - Announcements

Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company... Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. It owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. It is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription [Rx] business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter [OTC] products. It has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The Company in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.More

Announcements


ZLD Appendix 4D & FY24 Interim Financial ReportPRICE SENSITIVE22/02/24 download Created with Sketch. 4.98MB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/24 download Created with Sketch. 393.48KB
ZLD December 2023 Quarterly Activities ReportPRICE SENSITIVE31/01/24 download Created with Sketch. 1.49MB
ZLD Notification regarding unquoted securities - ZLD29/01/24 download Created with Sketch. 34.84KB
ZLD Notification of cessation of securities - ZLD23/01/24 download Created with Sketch. 21.61KB
ZLD Change of Auditor11/01/24 download Created with Sketch. 1.44MB
ZLD HOPE SPV receives US$819,000 second tranche of fundingPRICE SENSITIVE08/01/24 download Created with Sketch. 1.79MB
ZLD Change of Director's Interest Notice x 524/11/23 download Created with Sketch. 464.95KB
ZLD Notification regarding unquoted securities - ZLD24/11/23 download Created with Sketch. 23.63KB
ZLD Proposed issue of securities - ZLD23/11/23 download Created with Sketch. 46.95KB
ZLD Results of Meeting15/11/23 download Created with Sketch. 498.66KB
ZLD 2023 Annual General Meeting Presentation15/11/23 download Created with Sketch. 17.64MB
ZLD Notification of cessation of securities - ZLD13/11/23 download Created with Sketch. 21.52KB
ZLD Notification of cessation of securities - ZLD03/11/23 download Created with Sketch. 21.59KB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/23 download Created with Sketch. 199KB
ZLD September 2023 Quarterly Activities ReportPRICE SENSITIVE31/10/23 download Created with Sketch. 1.58MB
ZLD Letter to Shareholders16/10/23 download Created with Sketch. 166.98KB
ZLD Notice of Annual General Meeting/Proxy Form16/10/23 download Created with Sketch. 418.74KB
ZLD Appendix 4G and Corporate Governance Statement29/09/23 download Created with Sketch. 479.87KB
ZLD Annual Report to shareholders29/09/23 download Created with Sketch. 1.78MB
ZLD Change of registry address notification15/09/23 download Created with Sketch. 265.68KB
ZLD AGM Date and Closing Date for Director Nominations15/09/23 download Created with Sketch. 250.32KB
ZLD Change of Director's Interest Notice11/09/23 download Created with Sketch. 208.77KB
ZLD Notification of cessation of securities - ZLD11/09/23 download Created with Sketch. 25.36KB
ZLD Preliminary Final ReportPRICE SENSITIVE31/08/23 download Created with Sketch. 349.94KB
ZLD Zelira closes $3.25M funding as part of HOPE SPV fundraisePRICE SENSITIVE17/08/23 download Created with Sketch. 3.32MB
ZLD Notification of cessation of securities - ZLD14/08/23 download Created with Sketch. 21.73KB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE31/07/23 download Created with Sketch. 171.01KB
ZLD June 2023 Quarterly Activities ReportPRICE SENSITIVE31/07/23 download Created with Sketch. 1.72MB
ZLD Amendment to ASX announcement - Zelira's diabetic nerve pai08/06/23 download Created with Sketch. 1.71MB
ZLD Initial Director's Interest Notice01/06/23 download Created with Sketch. 144.34KB
ZLD Final Director's Interest Notice01/06/23 download Created with Sketch. 185.65KB
ZLD Proposed issue of securities - ZLD31/05/23 download Created with Sketch. 27.27KB
ZLD Zelira Non-Executive Director Appointed31/05/23 download Created with Sketch. 309.6KB
ZLD Top Line Results Investor Presentation31/05/23 download Created with Sketch. 1.88MB
ZLD Investor Webinar - Top line trial results31/05/23 download Created with Sketch. 1.38MB
ZLD Zeliras diabetic nerve pain drug outperforms LyricaPRICE SENSITIVE31/05/23 download Created with Sketch. 401.78KB
ZLD Trading HaltPRICE SENSITIVE29/05/23 download Created with Sketch. 282.45KB
ZLD ZLD secures additional US$3.25M investment in HOPE SPVPRICE SENSITIVE22/05/23 download Created with Sketch. 577.78KB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE27/04/23 download Created with Sketch. 158.23KB
ZLD March 2023 Quarterly Activities ReportPRICE SENSITIVE27/04/23 download Created with Sketch. 1.61MB
ZLD Section 708A Cleansing Notice21/03/23 download Created with Sketch. 237.76KB
ZLD Application for quotation of securities - ZLD21/03/23 download Created with Sketch. 24.73KB
ZLD Proposed issue of securities - ZLD15/03/23 download Created with Sketch. 24.89KB
ZLD Zelira raises A$1.77 million from US-based investorsPRICE SENSITIVE15/03/23 download Created with Sketch. 1.11MB
ZLD Trading HaltPRICE SENSITIVE13/03/23 download Created with Sketch. 610.74KB
ZLD Appendix 4D & FY23 Interim Financial ReportPRICE SENSITIVE28/02/23 download Created with Sketch. 3.4MB
ZLD Zelira HOPE 1 SPV Investor Presentation22/02/23 download Created with Sketch. 15.04MB
ZLD Initial Director's Interest Notice21/02/23 download Created with Sketch. 147.24KB
ZLD Zelira HOPE 1 SPV Investor Briefing Webinar21/02/23 download Created with Sketch. 434.03KB
ZLD Zelira Executive Director AppointedPRICE SENSITIVE20/02/23 download Created with Sketch. 505.42KB
ZLD Trading HaltPRICE SENSITIVE17/02/23 download Created with Sketch. 281.75KB
ZLD ZLD secures US$8.6 million funding for HOPE 1 US FDA trialsPRICE SENSITIVE15/02/23 download Created with Sketch. 991.52KB
ZLD Trading HaltPRICE SENSITIVE13/02/23 download Created with Sketch. 282.11KB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/23 download Created with Sketch. 169.11KB
ZLD December 2022 Quarterly Activities ReportPRICE SENSITIVE31/01/23 download Created with Sketch. 1.61MB
ZLD Zelira receives $1.14 million cash R&D Tax IncentivePRICE SENSITIVE30/01/23 download Created with Sketch. 1.09MB
ZLD Receipt of Creso Shares and Settlement of Health House loan10/01/23 download Created with Sketch. 1.22MB
ZLD Partial Receipt and variation of Health House loanPRICE SENSITIVE21/11/22 download Created with Sketch. 1.14MB
ZLD HHI: Scheme implementation deed executed21/11/22 download Created with Sketch. 1.49MB
ZLD ZLD Completes Enrolment for Diabetic Nerve Pain Drug TrialPRICE SENSITIVE21/11/22 download Created with Sketch. 2.27MB
ZLD New Constitution17/11/22 download Created with Sketch. 620.49KB
ZLD Results of Meeting17/11/22 download Created with Sketch. 278.23KB
ZLD 2022 Annual General Meeting Presentation17/11/22 download Created with Sketch. 15.28MB
ZLD Zelira Retail Investor Presentation14/11/22 download Created with Sketch. 3.18MB
ZLD Sydney Retail Investor Briefing Time Change11/11/22 download Created with Sketch. 1.26MB
ZLD Zelira Retail Investor Briefing Details04/11/22 download Created with Sketch. 1.25MB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/22 download Created with Sketch. 168.43KB
ZLD September 2022 Quarterly Activities ReportPRICE SENSITIVE31/10/22 download Created with Sketch. 1.82MB
ZLD Notice of Annual General Meeting/Proxy Form14/10/22 download Created with Sketch. 493.94KB
ZLD Letter to Shareholders14/10/22 download Created with Sketch. 168.75KB
ZLD Notification of cessation of securities - ZLD30/09/22 download Created with Sketch. 21.73KB
ZLD Diabetic Nerve Pain Drug Trial Summary Update21/09/22 download Created with Sketch. 530.15KB
ZLD AGM Date and Closing Date for Director Nominations21/09/22 download Created with Sketch. 1.21MB
ZLD Annual Report to shareholders16/09/22 download Created with Sketch. 1.97MB
ZLD ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds EnrolledPRICE SENSITIVE15/09/22 download Created with Sketch. 1.2MB
ZLD Partial Receipt of Health House Loan08/09/22 download Created with Sketch. 1.32MB
ZLD Investor Briefing Webinar Presentation07/09/22 download Created with Sketch. 15.23MB
ZLD Investor Briefing Webinar Details06/09/22 download Created with Sketch. 1.34MB
ZLD Zelira Full Year Results31/08/22 download Created with Sketch. 1.05MB
ZLD Appendix 4G31/08/22 download Created with Sketch. 346.38KB
ZLD Appendix 4E and Financial Report to ShareholdersPRICE SENSITIVE31/08/22 download Created with Sketch. 1.22MB
ZLD Response to ASX Aware QueryPRICE SENSITIVE05/08/22 download Created with Sketch. 848.36KB
ZLD June 2022 Quarterly Activities ReportPRICE SENSITIVE29/07/22 download Created with Sketch. 1.95MB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE29/07/22 download Created with Sketch. 156.55KB
ZLD Response to ASX Aware QueryPRICE SENSITIVE18/07/22 download Created with Sketch. 842.09KB
ZLD Response to ASX Price QueryPRICE SENSITIVE13/07/22 download Created with Sketch. 285.76KB
ZLD Zenivol receives formal BfArM approval in GermanyPRICE SENSITIVE13/07/22 download Created with Sketch. 1.37MB
ZLD Trading HaltPRICE SENSITIVE12/07/22 download Created with Sketch. 605.07KB
ZLD Pause in TradingPRICE SENSITIVE12/07/22 download Created with Sketch. 114.78KB
ZLD Termination of Scheme Implementation Deed with HHIPRICE SENSITIVE22/06/22 download Created with Sketch. 1.19MB
ZLD Trading HaltPRICE SENSITIVE20/06/22 download Created with Sketch. 603.21KB
ZLD Pause in TradingPRICE SENSITIVE20/06/22 download Created with Sketch. 114.38KB
ZLD EDCDM Technology License Agreement UpdatePRICE SENSITIVE14/06/22 download Created with Sketch. 234.71KB
ZLD Zenivol Longitudinal, RWD Trial in Insomnia ResultsPRICE SENSITIVE08/06/22 download Created with Sketch. 1.84MB
ZLD ZLD Completes Enrolment for Diabetic Nerve Pain Drug TrialPRICE SENSITIVE30/05/22 download Created with Sketch. 2.12MB
ZLD Hope 1 Longitudinal, Real-World Data Trial in ASD ResultsPRICE SENSITIVE17/05/22 download Created with Sketch. 603.74KB
ZLD Final Director's Interest Notice12/05/22 download Created with Sketch. 184.62KB
ZLD Director Resignation12/05/22 download Created with Sketch. 419.95KB
ZLD Investor Presentation - Non-deal Roadshow12/05/22 download Created with Sketch. 4.19MB
ZLD Appendix 4D & FY24 Interim Financial Report
22/02/24PRICE SENSITIVE download Created with Sketch. 4.98MB
ZLD Appendix 4C Cash Flow Report
31/01/24PRICE SENSITIVE download Created with Sketch. 393.48KB
ZLD December 2023 Quarterly Activities Report
31/01/24PRICE SENSITIVE download Created with Sketch. 1.49MB
ZLD Notification regarding unquoted securities - ZLD
29/01/24 download Created with Sketch. 34.84KB
ZLD Notification of cessation of securities - ZLD
23/01/24 download Created with Sketch. 21.61KB
ZLD Change of Auditor
11/01/24 download Created with Sketch. 1.44MB
ZLD HOPE SPV receives US$819,000 second tranche of funding
08/01/24PRICE SENSITIVE download Created with Sketch. 1.79MB
ZLD Change of Director's Interest Notice x 5
24/11/23 download Created with Sketch. 464.95KB
ZLD Notification regarding unquoted securities - ZLD
24/11/23 download Created with Sketch. 23.63KB
ZLD Proposed issue of securities - ZLD
23/11/23 download Created with Sketch. 46.95KB
ZLD Results of Meeting
15/11/23 download Created with Sketch. 498.66KB
ZLD 2023 Annual General Meeting Presentation
15/11/23 download Created with Sketch. 17.64MB
ZLD Notification of cessation of securities - ZLD
13/11/23 download Created with Sketch. 21.52KB
ZLD Notification of cessation of securities - ZLD
03/11/23 download Created with Sketch. 21.59KB
ZLD Appendix 4C Cash Flow Report
31/10/23PRICE SENSITIVE download Created with Sketch. 199KB
ZLD September 2023 Quarterly Activities Report
31/10/23PRICE SENSITIVE download Created with Sketch. 1.58MB
ZLD Letter to Shareholders
16/10/23 download Created with Sketch. 166.98KB
ZLD Notice of Annual General Meeting/Proxy Form
16/10/23 download Created with Sketch. 418.74KB
ZLD Appendix 4G and Corporate Governance Statement
29/09/23 download Created with Sketch. 479.87KB
ZLD Annual Report to shareholders
29/09/23 download Created with Sketch. 1.78MB
ZLD Change of registry address notification
15/09/23 download Created with Sketch. 265.68KB
ZLD AGM Date and Closing Date for Director Nominations
15/09/23 download Created with Sketch. 250.32KB
ZLD Change of Director's Interest Notice
11/09/23 download Created with Sketch. 208.77KB
ZLD Notification of cessation of securities - ZLD
11/09/23 download Created with Sketch. 25.36KB
ZLD Preliminary Final Report
31/08/23PRICE SENSITIVE download Created with Sketch. 349.94KB
ZLD Zelira closes $3.25M funding as part of HOPE SPV fundraise
17/08/23PRICE SENSITIVE download Created with Sketch. 3.32MB
ZLD Notification of cessation of securities - ZLD
14/08/23 download Created with Sketch. 21.73KB
ZLD Appendix 4C Cash Flow Report
31/07/23PRICE SENSITIVE download Created with Sketch. 171.01KB
ZLD June 2023 Quarterly Activities Report
31/07/23PRICE SENSITIVE download Created with Sketch. 1.72MB
ZLD Amendment to ASX announcement - Zelira's diabetic nerve pai
08/06/23 download Created with Sketch. 1.71MB
ZLD Initial Director's Interest Notice
01/06/23 download Created with Sketch. 144.34KB
ZLD Final Director's Interest Notice
01/06/23 download Created with Sketch. 185.65KB
ZLD Proposed issue of securities - ZLD
31/05/23 download Created with Sketch. 27.27KB
ZLD Zelira Non-Executive Director Appointed
31/05/23 download Created with Sketch. 309.6KB
ZLD Top Line Results Investor Presentation
31/05/23 download Created with Sketch. 1.88MB
ZLD Investor Webinar - Top line trial results
31/05/23 download Created with Sketch. 1.38MB
ZLD Zeliras diabetic nerve pain drug outperforms Lyrica
31/05/23PRICE SENSITIVE download Created with Sketch. 401.78KB
ZLD Trading Halt
29/05/23PRICE SENSITIVE download Created with Sketch. 282.45KB
ZLD ZLD secures additional US$3.25M investment in HOPE SPV
22/05/23PRICE SENSITIVE download Created with Sketch. 577.78KB
ZLD Appendix 4C Cash Flow Report
27/04/23PRICE SENSITIVE download Created with Sketch. 158.23KB
ZLD March 2023 Quarterly Activities Report
27/04/23PRICE SENSITIVE download Created with Sketch. 1.61MB
ZLD Section 708A Cleansing Notice
21/03/23 download Created with Sketch. 237.76KB
ZLD Application for quotation of securities - ZLD
21/03/23 download Created with Sketch. 24.73KB
ZLD Proposed issue of securities - ZLD
15/03/23 download Created with Sketch. 24.89KB
ZLD Zelira raises A$1.77 million from US-based investors
15/03/23PRICE SENSITIVE download Created with Sketch. 1.11MB
ZLD Trading Halt
13/03/23PRICE SENSITIVE download Created with Sketch. 610.74KB
ZLD Appendix 4D & FY23 Interim Financial Report
28/02/23PRICE SENSITIVE download Created with Sketch. 3.4MB
ZLD Zelira HOPE 1 SPV Investor Presentation
22/02/23 download Created with Sketch. 15.04MB
ZLD Initial Director's Interest Notice
21/02/23 download Created with Sketch. 147.24KB
ZLD Zelira HOPE 1 SPV Investor Briefing Webinar
21/02/23 download Created with Sketch. 434.03KB
ZLD Zelira Executive Director Appointed
20/02/23PRICE SENSITIVE download Created with Sketch. 505.42KB
ZLD Trading Halt
17/02/23PRICE SENSITIVE download Created with Sketch. 281.75KB
ZLD ZLD secures US$8.6 million funding for HOPE 1 US FDA trials
15/02/23PRICE SENSITIVE download Created with Sketch. 991.52KB
ZLD Trading Halt
13/02/23PRICE SENSITIVE download Created with Sketch. 282.11KB
ZLD Appendix 4C Cash Flow Report
31/01/23PRICE SENSITIVE download Created with Sketch. 169.11KB
ZLD December 2022 Quarterly Activities Report
31/01/23PRICE SENSITIVE download Created with Sketch. 1.61MB
ZLD Zelira receives $1.14 million cash R&D Tax Incentive
30/01/23PRICE SENSITIVE download Created with Sketch. 1.09MB
ZLD Receipt of Creso Shares and Settlement of Health House loan
10/01/23 download Created with Sketch. 1.22MB
ZLD Partial Receipt and variation of Health House loan
21/11/22PRICE SENSITIVE download Created with Sketch. 1.14MB
ZLD HHI: Scheme implementation deed executed
21/11/22 download Created with Sketch. 1.49MB
ZLD ZLD Completes Enrolment for Diabetic Nerve Pain Drug Trial
21/11/22PRICE SENSITIVE download Created with Sketch. 2.27MB
ZLD New Constitution
17/11/22 download Created with Sketch. 620.49KB
ZLD Results of Meeting
17/11/22 download Created with Sketch. 278.23KB
ZLD 2022 Annual General Meeting Presentation
17/11/22 download Created with Sketch. 15.28MB
ZLD Zelira Retail Investor Presentation
14/11/22 download Created with Sketch. 3.18MB
ZLD Sydney Retail Investor Briefing Time Change
11/11/22 download Created with Sketch. 1.26MB
ZLD Zelira Retail Investor Briefing Details
04/11/22 download Created with Sketch. 1.25MB
ZLD Appendix 4C Cash Flow Report
31/10/22PRICE SENSITIVE download Created with Sketch. 168.43KB
ZLD September 2022 Quarterly Activities Report
31/10/22PRICE SENSITIVE download Created with Sketch. 1.82MB
ZLD Notice of Annual General Meeting/Proxy Form
14/10/22 download Created with Sketch. 493.94KB
ZLD Letter to Shareholders
14/10/22 download Created with Sketch. 168.75KB
ZLD Notification of cessation of securities - ZLD
30/09/22 download Created with Sketch. 21.73KB
ZLD Diabetic Nerve Pain Drug Trial Summary Update
21/09/22 download Created with Sketch. 530.15KB
ZLD AGM Date and Closing Date for Director Nominations
21/09/22 download Created with Sketch. 1.21MB
ZLD Annual Report to shareholders
16/09/22 download Created with Sketch. 1.97MB
ZLD ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds Enrolled
15/09/22PRICE SENSITIVE download Created with Sketch. 1.2MB
ZLD Partial Receipt of Health House Loan
08/09/22 download Created with Sketch. 1.32MB
ZLD Investor Briefing Webinar Presentation
07/09/22 download Created with Sketch. 15.23MB
ZLD Investor Briefing Webinar Details
06/09/22 download Created with Sketch. 1.34MB
ZLD Zelira Full Year Results
31/08/22 download Created with Sketch. 1.05MB
ZLD Appendix 4G
31/08/22 download Created with Sketch. 346.38KB
ZLD Appendix 4E and Financial Report to Shareholders
31/08/22PRICE SENSITIVE download Created with Sketch. 1.22MB
ZLD Response to ASX Aware Query
05/08/22PRICE SENSITIVE download Created with Sketch. 848.36KB
ZLD June 2022 Quarterly Activities Report
29/07/22PRICE SENSITIVE download Created with Sketch. 1.95MB
ZLD Appendix 4C Cash Flow Report
29/07/22PRICE SENSITIVE download Created with Sketch. 156.55KB
ZLD Response to ASX Aware Query
18/07/22PRICE SENSITIVE download Created with Sketch. 842.09KB
ZLD Response to ASX Price Query
13/07/22PRICE SENSITIVE download Created with Sketch. 285.76KB
ZLD Zenivol receives formal BfArM approval in Germany
13/07/22PRICE SENSITIVE download Created with Sketch. 1.37MB
ZLD Trading Halt
12/07/22PRICE SENSITIVE download Created with Sketch. 605.07KB
ZLD Pause in Trading
12/07/22PRICE SENSITIVE download Created with Sketch. 114.78KB
ZLD Termination of Scheme Implementation Deed with HHI
22/06/22PRICE SENSITIVE download Created with Sketch. 1.19MB
ZLD Trading Halt
20/06/22PRICE SENSITIVE download Created with Sketch. 603.21KB
ZLD Pause in Trading
20/06/22PRICE SENSITIVE download Created with Sketch. 114.38KB
ZLD EDCDM Technology License Agreement Update
14/06/22PRICE SENSITIVE download Created with Sketch. 234.71KB
ZLD Zenivol Longitudinal, RWD Trial in Insomnia Results
08/06/22PRICE SENSITIVE download Created with Sketch. 1.84MB
ZLD ZLD Completes Enrolment for Diabetic Nerve Pain Drug Trial
30/05/22PRICE SENSITIVE download Created with Sketch. 2.12MB
ZLD Hope 1 Longitudinal, Real-World Data Trial in ASD Results
17/05/22PRICE SENSITIVE download Created with Sketch. 603.74KB
ZLD Final Director's Interest Notice
12/05/22 download Created with Sketch. 184.62KB
ZLD Director Resignation
12/05/22 download Created with Sketch. 419.95KB
ZLD Investor Presentation - Non-deal Roadshow
12/05/22 download Created with Sketch. 4.19MB
(20min delay)
Last
70.0¢
Change
-0.030(4.11%)
Mkt cap ! $7.943M
Open High Low Value Volume
73.0¢ 73.0¢ 70.0¢ $1.785K 2.485K

Buyers (Bids)

No. Vol. Price($)
1 2160 70.0¢
 

Sellers (Offers)

Price($) Vol. No.
76.0¢ 733 1
View Market Depth
Last trade - 14.24pm 29/03/2024 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.